$ASTS
No matter where the current price stands, it’s clear that within three years, this stock could be valued between $500 and $1,000 per share. This seems almost inevitable. For those who doubt, it might be time to rethink your stance.
$ASTS
A Game-Changing Technology on the Verge of Dominance
ASTS is poised to unveil a groundbreaking, disruptive technology that will soon be recognized as monopolistic, highly protected, and uniquely valuable. This innovation is set to drive the next era of ubiquitous,
Witness the historic launch of our first five BlueBird satellites! 🚀
From encapsulation in a rocket fairing to delivery into low Earth orbit, relive the excitement of this monumental milestone in our mission to connect the unconnected.
#ASTSpaceMobile
#BlueBirdLaunch
$ASTS
1. BlueWalker was in Low Earth Orbit for 2 years.
2. The BlueBird satellites are significantly larger and offer broadband speeds 10x faster.
3. The company reduced the number of satellites needed to cover the Earth from 248 to just 95.
4. With strategic partners, the
$ASTS
ASTS is planning for FirstNet funding next year, it seems. Wow. Warrants might be called this week, and possibly a Bell deal before launch. We're in great shape, 😊
$ASTS
No competition! By the way, our reach with partner subscribers is 2.8 billion, not 1.8 billion.
Applications: Full Internet access
Cost to users : $1 to $8 per month. Remember, we have a 50/50 deal with our partners, so our share is about $4. With 2.8 billion
$ASTS
This technology is truly one-of-a-kind, groundbreaking, and forward-looking, with the potential to dominate the market. The 3,500 patents ensure it remains the exclusive provider of direct-to-device 5G streaming, voice, and data services for years. Its applications extend
$ASTS
There are countless factors at play, including contracts, investments, and demand. I have a strong gut feeling that a major announcement is imminent. Mark my words.
$ASTS
Major News for $ASTS:
AT&T and Verizon have joined forces to urge the FCC to reject Starlink's proposal. Both companies are partners with $ASTS. If the FCC denies Starlink's plan, it would eliminate their biggest competitor in the U.S. market for the foreseeable future.
$ASTS
Currently at $25 Per Share—Future Gains of $25 Per Day are Coming
At $25 per share today, there will be a time when $ASTS sees regular gains of $25 per share. The strategy? Buy, hold, and avoid setting a stop loss. The recent success of ASTS’s Helene should be a wake-up
$ASTS
I’m saying this now so I can look back and repost it in a few years. It’s clear as day to me—ASTS, with its global reach, will grow to have a market cap bigger than all of our current big- MNO partners (whom we deeply appreciate for helping us become a powerhouse). In a
$ASTS
“Disrupt” the telecommunications landscape—disrupt being the key word here.
This technology is the most groundbreaking advancement since Alexander Graham Bell patented the telephone. AST SpaceMobile, with its protective moat of 3,400 U.S. patents, is set to dominate as
$ASTS
It's amusing to see the Bears enjoying themselves. Unfortunately for them, AST SpaceMobile has a history of dropping big news just when they think they're in control. Nothing will change the long-term value of this company or its technology. Nothing!
$ASTS
Six years ago, few could have predicted that Tesla would generate billions from carbon credits or hundreds of millions from monthly software subscriptions. Back then, the stock was around $16, and the company had been losing money for 17 consecutive years.
Now, looking
$ASTS
Why shorts and bears struggle to grasp the trajectory of this stock, which defies traditional advanced charting methods. Few have ever encountered such a disruptive technology, let alone had the opportunity to invest in it as a retail investor.
When Deutsche Bank analyzed
$ASTS
AST SpaceMobile's command center is advancing the BlueBird-1 satellites through key stages at a significantly quicker pace compared to BlueWalker 3. They're reaching critical checkpoints in merely 40% of the duration required for BlueWalker 3, and this is happening
$ASTS
This stock is an exceptionally rare opportunity, the kind we might only encounter a few times in our lifetime. A world-class company is being built right before our eyes, yet most people remain unaware. Just consider the lack of banking coverage—almost no one is covering
$IONQ
If you were seeking validation of the technology, the Air Force Research Lab following up last year's $25M contract with a $55M contract this year is about as strong as it gets.
$NIO
JP Morgan Reiterates Bullish Outlook on Nio After Visiting Onvo Stores
JP Morgan has reaffirmed its bullish stance on Nio $NIO after visiting the company's Onvo stores. Following the visit, analysts noted positive momentum and remain optimistic about the company's growth
$ASTS
Insider Monkey Ranks AST as 3rd Best Stock for 2024
According to Insider Monkey, AST SpaceMobile has been ranked as the 3rd best stock to watch in 2024. For more details, check out the full article on Yahoo Finance ().
$ASTS
It appears that fund managers are beginning to move into AST SpaceMobile, and this trend is likely just starting, with more to come. The remarkable upward trajectory we’re witnessing, which defies traditional charting, is expected to continue as the market recognizes the
$ASTS AST SpaceMobile finalizes construction of initial five commercial satellites dubbed Bluebirds
AST SpaceMobile announced the successful production of its first five commercial satellites, known as Bluebirds. Each satellite features communication arrays spanning 693 square
$ASTS
One of the smartest moves they've made is starting production on 17 satellites already. By sourcing the most critical components in advance, they’ve significantly reduced the risk of delays caused by parts shortages. This strategic approach greatly minimizes the chances of
$ASTS
For those considering selling, you might want to think twice—regret often follows. Every time I’m close to pulling the trigger, some big news drops. I’m holding onto every share.
$ASTS
ScotiaBank's upgrade of AST SpaceMobile's target price to $45.90 is a significant development. An analyst from Firstnet, who had previously dismissed the company, is now recognizing its revenue potential.
$NBIX
Neurocrine's Phase 2 Schizophrenia Data Viewed as 'Controversial,' Says Stifel
After Neurocrine released topline results from their Phase 2 study of NBI-1117568 for schizophrenia, Stifel noted that the data for the oral, muscarinic M4 selective agonist might be
$ENVX
In my opinion, it would be more beneficial if participants here shared valuable insights rather than simply criticizing those who sold (which may have aligned with their investment approach) or making generic statements like "Short sellers will face losses." I find these
$MAXN
Farewell, short sellers. You managed to cover 2 million shares, but today’s the deadline for your baseless lawsuits. With the best solar modules in the world, you’ve handed us an incredible opportunity to invest in a deeply undervalued stock. Share buybacks start this
$ASTS
Long-term investors have been patiently waiting for a positive announcement. While we understand that good news is on the horizon, allowing short sellers to dominate the stock has been a strategic misstep by management. The timing of releasing contracts and updates needs
$ASTS
Anyone claiming that Starlink outshines AST Spacemobile is completely misleading you.
To put it in perspective, if technology were cars, Starlink would be a Volkswagen Beetle, while AST Spacemobile is a Lamborghini. 🤷🏼♀️ There’s simply no comparison. Starlink can be jammed,
$ASTS
No Competition for AST SpaceMobile's Groundbreaking Technology
If you think there's competition for AST SpaceMobile, you're mistaken! There is no comparable technology in the market. Let’s clear up the confusion—SMS text messages are not the same as ubiquitous 5G.
In a
$JMIA
Did anyone catch the surge in volume yesterday after Elon met with African leaders in New York to discuss business opportunities on the continent? That was the signal to buy. It’s still not too late to jump in.
We're on the verge of a parabolic move back to $10.
$ASTS
shorts are misguided due to a lack of proper research. Many are simply following charts without grasping the significance of this groundbreaking, disruptive technology. It’s time they realize how dramatically undervalued this still is. 😊
$ASTS
Why shorts and bears struggle to grasp the trajectory of this stock, which defies traditional advanced charting methods. Few have ever encountered such a disruptive technology, let alone had the opportunity to invest in it as a retail investor.
When Deutsche Bank analyzed
$ASTS
Launch Provider: SpaceX Falcon 9
Payload: 5 BlueBird satellites equipped with the largest-ever commercial communications arrays to be deployed in Low Earth Orbit (LEO), boasting an impressive 693 square feet—marking a significant technological advancement for AST
$ASTS
It seems that the T-Mobile and Starlink texting service won’t be launching in 2024. Do you think T-Mobile might start feeling some FOMO soon ? 😊
.
$ASTS
Nvidia soared 181% in a year, but ASTS is saying, "Watch this!" Up 866% and just getting started. This could be the best stock to hold this decade—bookmark it! 💃🏼💃🏼
$ENVX
Investors, it's time to consider your strategy: are you playing the short-term algorithmic trading game today, or focusing on the broader perspective?
I've reviewed the first page of Oppenheimer's latest report on ENVX. Here's a brief summary from their morning client
$ASTS
Absolutely exciting news! 1. BB1 is prepped for launch with 17 more satellites in progress. 2. They can launch 4-8 at a time. 3. Government deals and funding are advancing, 4. Regulatory approvals are moving forward, and 5. MNO partnerships are developing well. Not only
$ASTS
To the bears concerned about the cost of the constellation: I say, thank goodness! With heavyweights like AT&T, Verizon, Vodafone, Rakuten, and a ton of MNOs with billions at their disposal not to mention funding from FirstNet and the DoD—we’re covered.
There are also
$OCGN Ocugen secures FDA green light for Expanded Access Program targeting retinitis pigmentosa patients
Ocugen revealed that the FDA has authorized the initiation of its expanded access program for treating adult individuals, 18 years and above, diagnosed with retinitis
$SMCI
Supermicro Short Report "Largely Lacks Details," Says JPMorgan
JPMorgan maintains its Overweight rating on Supermicro following the release of a short report by Hindenburg Research, which accuses the company of accounting manipulation, sibling self-dealing, and sanction
$MAXN
Our price won't stay this low for much longer
$2.4 billion in Industrial Revenue Bonds from the City of New Mexico
$1 billion from the Department of Energy
And we're trading at just $0.17 per share?
$MAXN
I’m confident that the future of Maxeon Solar Technologies is more promising than challenging, which is why I’m all in. Looking forward to Monday with optimism! 😊💃🏼
$ASTS
From the highlighted paragraphs in the news release, it’s clear they’re in talks with new partners. Just imagine the impact when that news breaks, especially with service going live in a few months. This is the time to Load up! 🚨🚨
$MAXN
In November 2019, TCL invested $298 million in Maxn, acquiring a 28.85% stake in the company, valuing Maxn at approximately $1 billion at the time, with an IPO share price of $18 per share. Since then, TCL's investment has seen significant losses. Like any investor facing
$HUMA
Quotes from the three doctors on the call:
• This is going to revolutionize the field.
• This will replace prosthetics in bypass, period.
• I don’t think there’s any alternative to the ATEV. It doesn’t require much preparation just cut it out of the plastic, flush it,
$NNOX
Nano-X Imaging announced that its deep-learning medical imaging analytics subsidiary, , has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for HealthCCSng V2.0. This upgraded version of 's cardiac
$SAVA Kudos to long-term SAVA investors for an impressive performance over the recent trading sessions. $SAVA has surged 69.9% in the last 30 days. Remarkable.
$ASTS
End of Quarter Today—Watching for Potential Buying Activity
As today marks the final day of the quarter, it's noteworthy that $ASTS was trading around $11 at the start of Q3 on July 1. It will be interesting to see if we observe net buying today. Institutions and funds
$NVAX
Roger touched base with management!
Jefferies analyst Roger Song reiterated a Buy rating with a $31.00 price target on Novavax (NASDAQ: NVAX).
The analyst commented: “We connected with management. With timely approval/recommendation, strong product presentation, and
$VKTX
Please see the attached first page of a Morgan Stanley report on VKTX, dated 8/12. Morgan Stanley has an 'Overweight' rating on VKTX with a price target of $105.
By the way, am I the only one who finds it ironic that they’ve assigned an 'Overweight' rating to a company
$BIDU
Baidu reports Q2 EPS of $2.89, beating the consensus of $2.58.
Q2 revenue came in at $4.67 billion, slightly below the consensus estimate of $4.7 billion. ‘AI Cloud continued to accelerate in the second quarter, offsetting the ongoing macro headwinds for online marketing
$ASTS
The trend continues, and I believe a significant announcement is on the horizon—it's rarely kept completely under wraps. Good luck to the true believers. The biggest challenge here is tuning out the shorts. 😊
$ASTS
It appears that fund managers are beginning to move into AST SpaceMobile, and this trend is likely just starting, with more to come. The remarkable upward trajectory we’re witnessing, which defies traditional charting, is expected to continue as the market recognizes the
$ASTS
Must-Watch Video on AST SpaceMobile’s Revolutionary Technology
Check out this video to learn more about AST SpaceMobile’s game-changing satellite-to-device technology. This is a key moment for the company as it works toward delivering 100% global
$MAXN $SPY
Maxeon Solar Technologies is gearing up to release its earnings next week, and the outlook is bright! The global push towards renewable energy is boosting demand for Maxeon’s high-efficiency solar panels. Their new manufacturing facility in New Mexico is set to be a
$ASTS
The technology has dual-use potential for government and commercial sectors, meaning they'll receive funding from both the US government and private industry. Two new US government contracts have just been secured, marking the beginning of much larger deals to come!
$JMIA
Smart money is tracking the same news I am. With triple the volume today, it's clear this is going to take off quickly. Shorts are caught off guard and are about to face a tough squeeze. Options activity is set to push this to $6 by tomorrow.
$ASTS
Anticipating a Catalyst to Propel Us Back to ATH
Excited for the upcoming week and the potential catalyst that could push us back to our all-time high. Best of luck to the Spacemob and long-term investors who stayed the course, ignoring the noise from penny flippers and
$JMIA
Solid Sideways Consolidation Today
Today's session saw some healthy sideways consolidation, closing just slightly in the green with strong buying pressure in the final 15 minutes. Tomorrow could bring more upward momentum, in my opinion.
Things could get really
$ENVX
The following is a summary of the Benchmark analysis on Enovix Corporation:
Enovix Corporation (ENVX, Buy, $14.41) Electric Vehicles/Supply Chain
Q2 2024 Analysis, Revenue Exceeds Expectations with Significant Commercial Client Advancements; Maintain Buy Recommendation
$ASTS
Major fund managers and investment firms are starting to take notice of AST SpaceMobile. Unlike the shorts, they've done their homework. Trying to halt this momentum is like trying to stop the ocean tide—it’s unstoppable as they recognize the revenue potential. Disruptive
$JMIA
According to Akinwumi Adesina, President of the African Development Bank, on Bloomberg TV, $90 billion from the World Bank is set to electrify Africa within six months, with an additional $277 billion dedicated to Sustainable Development Goals (SDG). Plus, private capital
$JMIA
I’ve seen this happen a few times with this stock over the past few years, and it feels like it’s ready to run again. Today could potentially be the biggest day we’ve had since the drop in August. We’re sitting right at the level where we landed after the gap down from 9.
$JMIA
Everyone’s down today, just following the broader market. Nothing to worry about. Some good news or upcoming earnings could trigger a rebound. Stay patient.
$LQDA
Liquidia and Pharmosa Biopharm modify exclusive licensing agreement
Liquidia and Pharmosa Biopharm have announced a modification to their existing exclusive licensing agreement for the development and commercialization of L606, an inhaled, sustained-release formulation of
$HUM
Receives a $2.5B annual bonus from CMS based on its current Star rating. In the worst-case scenario, the company could face a $2.5B revenue hit in 2026, representing a 2% impact on annual revenue this assumes the rating remains unchanged and Humana takes no action.
This
$SERV is $20 today and is expected to reach $30 by Tuesday. Companies like Nvidia, Uber, Hero Delivery, and Seven Eleven are making smart moves. Do you really think Nvidia is involved in pump and dump schemes? This isn’t a penny stock. It’s on its way to a billion-dollar market
$ENVX
Canaccord has increased the price target for Enovix from $17 to $20, while maintaining a Buy rating on the stock. The firm highlighted that as artificial intelligence (AI) becomes more prevalent, its significant energy demands are putting pressure on our power grid
$SAVA Keep in mind that most retail investors holding significant positions acquired shares below $20 or even $15. It's typical for them to secure profits or implement stop-loss orders on volatile days like today. Additionally, day traders likely contributed to the sharp decline
$ENVX
Attached is the first page from Oppenheimer’s report on ENVX, dated August 26, 2024.
Oppenheimer maintains an ‘Outperform’ rating on ENVX with a price target of $36.
Of course, some bears on this board might argue that Oppenheimer issued this report solely to facilitate
$JMIA
Jumia’s Primary Goal is to Achieve Profitability Swiftly, Says Report
According to a recent article, Jumia is focused on becoming a profitable company as soon as possible. The e-commerce platform is implementing strategic measures to streamline operations and drive growth
$ENVX
For those struggling to read the attached document, here's a summary of their investment recommendation:
"In the past, bandwidth was the limiting factor; that was the prevailing wisdom. Internet infrastructure was expanding rapidly as software developers demanded 'wider'
$ENVX
In my opinion, it would be more beneficial if participants here shared valuable insights rather than simply criticizing those who sold (which may have aligned with their investment approach) or making generic statements like "Short sellers will face losses." I find these
$ASTS
• AST SpaceMobile is developing the largest commercial phased array antennas in low Earth orbit to enhance mobile network operators’ capabilities while preventing harmful interference with neighboring spectrum users.
• Full commercial deployment is in sight, pending
$JMIA Jumia Technologies announces Q2 revenue of $36.5M compared to $44M in previous year
Gross Merchandise Value (GMV) reached $170.1M, a 5% year-over-year decline, but a 35% increase in constant currency. Operating deficit decreased 8% year-over-year to $20.2M from $22.1M in
$CAPR
The potential here is widely regarded as massive, given the overwhelming need and the anticipated surge of biologic drugs set to emerge from pipelines in the coming years.
Exosome-based delivery is a true industry disruptor. These exosomes, derived from the body’s own
$ASTS
Pay attention: 17 BlueBird 2 satellites are currently under construction. Additional contracts with prepayments are on the verge of being signed, and they’re set to collect over $100 million from the warrants.
The five BlueBird 1 satellites launching in September will
$JMIA
It’s great to see Dufay stepping up to boost visibility for $JMIA. Telling the company’s story is something that has been noticeably lacking, so it’s encouraging to see more effort in this direction.
$ENPH I’d like to highlight this statement from Badri: “We are more than 85% booked toward the midpoint of our revenue guidance, which is $390 million. This represents the strongest backlog position we’ve had in the past year.
$ASTS
No dilution, rockets launching in a few weeks, and another launch scheduled for early next year. Plus, it sounds like profits could be on the horizon before the year ends. That sounds like a solid quarterly report to me. Big changes are coming soon!
$ASTS
AST SpaceMobile reports Q2 EPS of (51c) compared to (24c) last year
"We are at a pivotal moment for AST SpaceMobile," said Abel Avellan, Founder, Chairman, and CEO of the company. "The arrival of our first five commercial satellites at the launch site represents the
$ASTS
With cash reserves, upcoming warrant conversions, and expected prepayments and milestone payments as satellites are deployed, we’re in a strong position. The next few months will bring numerous positive updates—from filings and contracts to events—each acting as a
$ASTS
Wow, you bears are really missing the mark! Let me break it down for you:
1. No dilution or offering this year—4.5 months of peace of mind, as confirmed by the CEO.
2. Several catalysts on the horizon, including the launch, deployment, successful testing, going live,
$FUBO FuboTV upgrades FY24 revenue outlook to $1.57B-$1.59B from previous $1.53B-$1.55B
Analyst consensus stands at $1.57B. Fubo is elevating its previously announced guidance, now expecting 1,725,000 to 1,745,000 paid subscribers, representing a 7% year-over-year increase at
$UPST Upstart rating elevated to Positive from Negative at Mizuho
Mizuho significantly raised Upstart's rating to Positive from Negative, adjusting the price target to $31 from $17. The analyst informs investors in a research report that the company "lacks widespread support"
$NVAX For those speculating on a significant short-covering rally, consider these potential entry strategies:
1. Accumulate during the next pullback if the stock fails to hold above $17
2. Initiate a position on a convincing move above $17
3. Enter the trade upon a decisive
$JKS, $DQ, $CSIQ | Eolian and photovoltaic energy will constitute over 40% of China's aggregate installed power capacity by year's end, eclipsing coal-based capacity for the first time, according to CEC reports.
During H1, wind and solar comprised 38.4% of total capacity, while
$URGN
Attached is the first page of Oppenheimer’s ‘Company Update’ on URGN from this morning. They maintain an ‘Outperform’ rating with a $40 price target on the stock.